Risk Assessment for On-Site Inspections
Recommendation
21-23 May 2025
Copenhagen, Denmark
Initial and Continuous Professional Training for GMP Auditors
Register now for ECA's GMP Newsletter
Due to the pandemic-related travel restrictions, supervising authorities are currently mostly carrying out so-called distant assessments. However, most inspectorates also carry out partial on-site inspections, sometimes even unannounced.
The PIC/S has now developed a "Covid-19 Risk Assessment for National Routine On-Site Inspections". This risk assessment is based on a FMEA (Failure Mode and Effects Analysis) and should be carried out during the planning phase of the inspection together with the company to be inspected.
Topics to be discussed and assessed include:
- Limitation of possible COVID-19 exposure for inspectors
- Clothing (e.g. it is recommended to take off jewellery and to wear waterproof shoes)
- Cleaning of the workplace and materials used
- National guidelines for face coverings
- General hygiene guidelines
But what about unannounced inspections?
If an unannounced inspection has to take place, an "individual bespoke risk assessment" should be carried out; the assessment suggested in the document should then not be used.
Related GMP News
08.01.2025PIC/S publishes Guidance Documents on Remote Assessments
04.12.2024Discarded Batch Documentation again found during Inspection
30.10.2024From missing Analysis to Brand Protection Violations - FDA Warning Letter to Canadian Manufacturer
23.10.2024Root Cause Analysis: What can be found in FDA Warning Letters?
23.10.2024Do you want to host FDA Staff? FDA announces Experiential Learning Site Visit Program
09.10.2024Management circumvents Quality Department in Deviation Classification - FDA Warning Letter